GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avinger Inc (NAS:AVGR) » Definitions » Altman Z-Score

Avinger (Avinger) Altman Z-Score : -38.64 (As of May. 24, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Avinger Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of -38.63 is in distress zone. This implies bankruptcy possibility in the next two years.

Avinger has a Altman Z-Score of -38.64, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Avinger's Altman Z-Score or its related term are showing as below:

AVGR' s Altman Z-Score Range Over the Past 10 Years
Min: -46.71   Med: -17.54   Max: -0.72
Current: -38.63

During the past 12 years, Avinger's highest Altman Z-Score was -0.72. The lowest was -46.71. And the median was -17.54.


Avinger Altman Z-Score Historical Data

The historical data trend for Avinger's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avinger Altman Z-Score Chart

Avinger Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.96 -15.10 -17.53 -24.71 -46.71

Avinger Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.91 -36.90 -35.07 -46.71 -38.64

Competitive Comparison of Avinger's Altman Z-Score

For the Medical Instruments & Supplies subindustry, Avinger's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avinger's Altman Z-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avinger's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Avinger's Altman Z-Score falls into.



Avinger Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Avinger's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*-0.3525+1.4*-25.2795+3.3*-1.035+0.6*0.2299+1.0*0.4521
=-38.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2024:
Total Assets was $16.86 Mil.
Total Current Assets was $14.12 Mil.
Total Current Liabilities was $20.06 Mil.
Retained Earnings was $-426.21 Mil.
Pre-Tax Income was -5.517 + -5.024 + -4.476 + -4.176 = $-19.19 Mil.
Interest Expense was -0.416 + -0.427 + -0.455 + -0.445 = $-1.74 Mil.
Revenue was 1.859 + 1.906 + 1.817 + 2.041 = $7.62 Mil.
Market Cap (Today) was $4.81 Mil.
Total Liabilities was $20.91 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(14.121 - 20.064)/16.86
=-0.3525

X2=Retained Earnings/Total Assets
=-426.213/16.86
=-25.2795

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-19.193 - -1.743)/16.86
=-1.035

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=4.809/20.914
=0.2299

X5=Revenue/Total Assets
=7.623/16.86
=0.4521

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Avinger has a Altman Z-Score of -38.64 indicating it is in Distress Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Avinger  (NAS:AVGR) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Avinger Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Avinger's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Avinger (Avinger) Business Description

Traded in Other Exchanges
N/A
Address
400 Chesapeake Drive, Redwood City, CA, USA, 94063
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO) and Pantheris, image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
Executives
Crg Partners Iii (cayman) Unlev Aiv I L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii (cayman) Lev Aiv I L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii - Parallel Fund B (cayman) L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Cr Group L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii - Parallel Fund (a) L.p. 10 percent owner C/O CAPITAL ROYALTY L.P., 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Nabeel Paul Subainati officer: Vice President, Finance 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
James Cullen director 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Mark Weinswig officer: Chief Financial Officer EMCORE CORP, 10420 RESEARCH ROAD, SE, ALBUQUERQUE NM 87123
Himanshu Patel officer: Chief Technology Officer C/O AVINGER, INC., 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
Jeffrey M Soinski director, officer: President and CEO 585 WEST 500 SOUTH, BOUNTIFUL UT 84010
Tamara Elias director 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
Simpson John B Ph D Md director, 10 percent owner C/O FOXHOLLOW TECHNOLOGIES, INC., 740 BAY ROAD, REDWOOD CITY CA 94063
Matthew Ferguson officer: CBO, CFO & Treasurer C/O FOXHOLLOW TECHNOLOGIES, INC., 740 BAY ROAD, REDWOOD CITY CA 94063
John D. Simpson officer: Sr. VP, Sales & Marketing C/O AVINGER, INC., 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063